
    
      PRIMARY OBJECTIVES:

      I. Establish the comparative effectiveness of the Collaborative Care to Preserve Performance
      in Cancer (COPE) trial arms in preserving functional mobility.

      II. To assess the comparative cost-effectiveness and cost-utility of the COPE interventions.

      OUTLINE: Patients are randomized to 1 of 3 arms.

      ARM I: Patients undergo enhanced usual care comprising telephonic monitoring with monthly
      status reports provided to their oncology care teams for 6 months.

      ARM II: Patients undergo enhanced usual care as in Arm I and participate in an individualized
      conditioning program delivered telephonically by the Fitness Care Manager (FCM) and adapted,
      as required, by a local physical therapist for 6 months.

      ARM III: Patients undergo enhanced usual care as in Arm I, participate in an individualized
      conditioning program coordinated by the FCM as in Arm II, and receive optimized pain
      management through a nurse Pain Care Manager (PCM) for 6 months.
    
  